Sartorius Stedim Biotech Partners with Nova Biomedical

Sartorius Stedim Biotech (SSB), Aubagne, France, recently announced an agreement to integrate the BioProfile Flex2 analyzer from Nova Biomedical (Nova), Waltham, Mass, into Ambr multiparallel bioreactor systems for automated, at-line cell culture analytics....
GenomeDx Biosciences Launches Bladder Cancer Assay

GenomeDx Biosciences Launches Bladder Cancer Assay

GenomeDx Biosciences, San Diego, has launched the Decipher bladder cancer classifier following publication of a study supporting its development and validation.1 According to the company, the clinical assay subtypes muscle-invasive bladder cancer (MIBC) with a high...
Vigilant Biosciences Commences Studies of Oral Cancer Test

Vigilant Biosciences Commences Studies of Oral Cancer Test

Vigilant Biosciences Inc, Fort Lauderdale, Fla, has launched patient enrollment for clinical studies of its OncAlert point-of-care qualitative assay in support of its premarket regulatory submission to FDA. Vigilant Biosciences’ initial clinical study is designed to...

Scanning Electron Microscope Offers Enhanced Resolution

Zeiss, Oberkochen, Germany, presents a new generation of focused ion beam scanning electron microscopes (FIB-SEMs) with the Zeiss Crossbeam 550, which features an increase in resolution for imaging and material characterization and a speed gain in sample preparation....
FDA Clears Hologic HSV Assay

FDA Clears Hologic HSV Assay

Hologic Inc, Marlborough, Mass, has obtained FDA clearance to market its Aptima herpes simplex virus (HSV) 1 and 2 molecular assay on the fully automated Panther system. The test will be commercially available in the United States, US territories, and Puerto Rico....